Navigation Links
Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
Date:4/24/2008

current standard of care, and patients with non-alcoholic fatty liver disease (NAFLD), there are currently no therapeutic options available to prevent progression to cirrhosis, liver failure and liver cancer," stated Dr. Gane. "In the future, these patients may benefit from maintenance therapy with interventions such as MitoQ, which block either hepatic necroinflammation or fibrogenesis."

"In the coming year, Antipodean plans to explore and develop its lead compound for the treatment of hepatological diseases, particularly non- alcoholic fatty liver disease (NAFLD)," said Ken Taylor, Ph.D., Chief Executive Officer of Antipodean Pharmaceuticals. "The Company is actively seeking to achieve this goal with the help of a pharmaceutical partner."

A 12-month study in patients in Parkinson's disease showed MitoQ to be well tolerated; however, there was no significant effect on disease progression. Dr. Barry Snow, Department of Neurology, Auckland Hospital, New Zealand and Principal Investigator of the trial of MitoQ in Parkinson's disease, believes that the lack of efficacy in Parkinson's Disease may have been due to the large number of impaired cells in that disease; these cells may have had limited or no ability to regenerate, and thus could not benefit from MitoQ's antioxidant properties. The Company believes MitoQ has therapeutic potential in diseases where cell regeneration occurs, such as hepatological and dermatological disorders.

About MitoQ(R)

MitoQ(R) is a mitochondria-targeted antioxidant that selectively blocks mitochondrial oxidative damage and prevents liver cell apoptosis. MitoQ is based on a novel technology, targeted lipophilic cations that transport and concentrate antioxidants into the mitochondria-organelles inside cells that provide energy for life processes-where they accumulate up to a thousand fold. Targeted antioxidants can reduce the hepatic oxidative damage that is induced by viral infection and that is also involved in
'/>"/>

SOURCE Antipodean Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
2. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
3. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
4. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
5. Amylin Pharmaceuticals Reports First Quarter Financial Results
6. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
7. Access Pharmaceuticals Announces New Data on Angiolix(R)
8. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
9. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
10. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
11. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... According ... and the American Heart Association have released new guidelines to educate doctors and patients ... last update to these particular guidelines came in 2007, so the new version is ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital (AGH), part ... medical centers in the United States to receive international recognition for an advanced, ... Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare institutions dedicated ...
(Date:8/27/2015)... ... , ... About 10 percent of mothers experienced chronic, persistent ... more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated ... While most people don’t develop persistent depression after a major disaster like that, ...
(Date:8/27/2015)... Hills, CA (PRWEB) , ... August 27, 2015 ... ... Wearables & IoT Summit , scheduled for October 27-29, 2015 in San Jose, ... technology, the summit will primarily focus on the void that exists where battery ...
Breaking Medicine News(10 mins):Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
... of Women,s ... Ovarian Reserve, COLORADO ... announced it will be the first IVF center,in the region to ... an assessment of a woman,s egg supply by combining,multiple factors including ...
... claims companies knowingly misled consumers on the use of Zetia and ... ... Hagens Berman Sobol Shapiro filed,a proposed class-action lawsuit against Merck (NYSE: ... Vytorin alleging,Merck and Schering-Plough violated state consumer protection laws arising,from the sale ...
... Inc. (TSX: DDS,NASDAQ: DDSS) today announced that it ... iNova Pharmaceuticals (Australia) Pty Limited,for its once-daily tramadol ... of our once-daily tramadol product across,Europe and in ... as we,prepare for additional product launches in key ...
... 24 Weight Watchers,International, Inc. (NYSE: WTW ) ... year 2007 after the NYSE close on Thursday, February ... call on February 14th at,5:00 p.m. ET. During the ... Ann Sardini, Chief Financial Officer, will,discuss fourth quarter and ...
... with a camera could detect the earliest signs of cancer? ... in confined spaces. Such a device could find warning signs ... States. , A fundamentally new design has created a smaller ... to use than current technology. Its first use on a ...
... published today in the February issue of the ... of Biomaterials, Dalhousie University (Halifax, NS, Canada), and ... on Dentistry, denounces new Norwegian regulations governing the ... use of dental amalgam not only in Norway, ...
Cached Medicine News:Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 2Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 3Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 4Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 2Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 3Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Earnings Conference Call 2Health News:Camera in a pill offers cheaper, easier window on your insides 2Health News:Camera in a pill offers cheaper, easier window on your insides 3Health News:Materials expert denounces Norwegian ban on dental amalgam 2
(Date:8/27/2015)... , Aug. 27, 2015  BioElectronics Corporation (OTC Pink: BIEL), ... that three abstracts featuring the use of ActiPatch®, its ... 9 th Congress of the European Pain Federation ... September 2015. The Company will also be exhibiting ... Gianluca Bagnato , department clinical and experimental rheumatology ...
(Date:8/27/2015)... ATLANTA , August 27, 2015 ... Consortium convened in Boston on ... Consortium in an effort to more fully exploit the ... are applied to brain diseases. "As an ... has a responsibility to assume a leadership role - ...
(Date:8/27/2015)... FRANCISCO, Calif. , Aug. 27, 2015 /PRNewswire/ ... therapeutics for the treatment of cancer, today announced ... member of the company,s Board of Directors, has ... led immuno-oncology at Eli Lilly and AstraZeneca, and ... first FDA approved checkpoint inhibitor, at Bristol-Myers Squibb ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: